NeuroScientific Biopharmaceuticals Limited Price Chart
NeuroScientific Biopharmaceuticals Limited NSB.XA Financial and Trading Overview
Contents
- NeuroScientific Biopharmaceuticals Limited Price Chart
- NeuroScientific Biopharmaceuticals Limited NSB.XA Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of NeuroScientific Biopharmaceuticals Limited
- Q&A For NeuroScientific Biopharmaceuticals Limited Stock
| NeuroScientific Biopharmaceuticals Limited stock price | 0.04 AUD |
| Previous Close | 0.09 AUD |
| Open | 0.08 AUD |
| Bid | 0.08 AUD x N/A |
| Ask | 0.11 AUD x N/A |
| Day's Range | 0.08 - 0.08 AUD |
| 52 Week Range | 0.07 - 0.28 AUD |
| Volume | 14.77K AUD |
| Avg. Volume | 16.21K AUD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.665798 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.044 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NSB.XA Valuation Measures
| Enterprise Value | 9.59M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 4.263158 |
| Enterprise Value/Revenue | 8.275 |
| Enterprise Value/EBITDA | -1.231 |
Trading Information
NeuroScientific Biopharmaceuticals Limited Stock Price History
| Beta (5Y Monthly) | 0.665798 |
| 52-Week Change | -52.63% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.28 AUD |
| 52 Week Low | 0.07 AUD |
| 50-Day Moving Average | 0.09 AUD |
| 200-Day Moving Average | 0.14 AUD |
NSB.XA Share Statistics
| Avg. Volume (3 month) | 16.21K AUD |
| Avg. Daily Volume (10-Days) | 16.6K AUD |
| Shares Outstanding | N/A |
| Float | 98.27M |
| Short Ratio | N/A |
| % Held by Insiders | 33.32% |
| % Held by Institutions | 4.27% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -677.62% |
| Gross Margin | 95.49% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -70.67% |
| Return on Equity (ttm) | -123.53% |
Income Statement
| Revenue (ttm) | 1.16M AUD |
| Revenue Per Share (ttm) | 0.008 AUD |
| Quarterly Revenue Growth (yoy) | 1482.40% |
| Gross Profit (ttm) | -66718 AUD |
| EBITDA | -7787557 AUD |
| Net Income Avi to Common (ttm) | -7764243 AUD |
| Diluted EPS (ttm) | -0.044 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.33M AUD |
| Total Cash Per Share (mrq) | 0.02 AUD |
| Total Debt (mrq) | 0 AUD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.207 |
| Book Value Per Share (mrq) | 0.019 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6172138 AUD |
| Levered Free Cash Flow (ttm) | -3315288 AUD |
Profile of NeuroScientific Biopharmaceuticals Limited
| Country | Australia |
| State | WA |
| City | Cottesloe |
| Address | 85 Forrest Street |
| ZIP | 6011 |
| Phone | 61 8 6382 1805 |
| Website | https://www.neuroscientific.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies. Its lead drug candidates include EmtinB for treatment of neurodegenerative dementia and Alzheimer's disease, and degenerative conditions of the optic nerve. The company was incorporated in 2002 and is based in Cottesloe, Australia.
Q&A For NeuroScientific Biopharmaceuticals Limited Stock
What is a current NSB.XA stock price?
NeuroScientific Biopharmaceuticals Limited NSB.XA stock price today per share is 0.04 AUD.
How to purchase NeuroScientific Biopharmaceuticals Limited stock?
You can buy NSB.XA shares on the Cboe AU exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NeuroScientific Biopharmaceuticals Limited?
The stock symbol or ticker of NeuroScientific Biopharmaceuticals Limited is NSB.XA.
How many shares does NeuroScientific Biopharmaceuticals Limited have in circulation?
The max supply of NeuroScientific Biopharmaceuticals Limited shares is 0.
What is NeuroScientific Biopharmaceuticals Limited Price to Earnings Ratio (PE Ratio)?
NeuroScientific Biopharmaceuticals Limited PE Ratio is now.
What was NeuroScientific Biopharmaceuticals Limited earnings per share over the trailing 12 months (TTM)?
NeuroScientific Biopharmaceuticals Limited EPS is -0.044 AUD over the trailing 12 months.